Boehringer Ingelheim and Astellas extend Japan telmisartan pact
This article was originally published in Scrip
Executive Summary
Boehringer Ingelheim and Astellas have extended their Japanese commercial alliance for the Micardis family of products (telmisartan and combinations) by four years to December 2016.